02/23/2021 | News release | Distributed by Public on 02/23/2021 05:38
va-Q-tec, pioneer of highly efficient products and solutions in the field of thermal insulation and temperature-controlled supply chains (TempChain logistics), ensures temperature-controlled pharmaceutical logistics on the last mile with its innovative transport boxes. Reliable temperature stability is not only relevant for the transport of the CoVid-19 vaccine but for a wide range of products in the pharmaceutical industry. Due to the increasing complexity and requirements of novel biotech drugs and vaccines, the proportion of temperature-controlled transports requiring various constant temperature ranges has been rising sharply for several years. In this context, the 'last mile', i.e. the final delivery stage to the final destination such as doctors' offices, hospitals or to the patients' homes, poses growing challenges for the industry worldwide. The constant and safe temperature chain required for vaccine and drug logistics during storage and transport must also be strictly adhered to during this last transport stage in order to ensure the effectiveness of the sensitive products.
va-Q-med boxes have not only been used for the increased demand of the Corona vaccine distribution, but for several years now, the high-tech thermoboxes have been proving their optimal suitability for transporting products on the last mile for various projects involving pharmaceuticals or clinical samples. They are used in different climatic zones such as the hot and humid regions of Southeast Asia as well as in cold Scandinavia. Their performance has been individually optimized for these extreme climatic conditions. For several months now, in the Netherlands, a dedicated rental system was developed and executed in close cooperation with a logistics provider to supply individualized medications directly from the hospital. The delivery service takes care of transporting the temperature-sensitive goods between the clinic and the patients' homes with the help of va-Q-med boxes. This ensures optimum quality and rapid delivery of the temperature-sensitive pharmaceuticals.
Dr. Joachim Kuhn, CEO and Chairman of the Board of va-Q-tec, considers the last mile to be the most immense challenge in current Corona vaccine logistics and future pharmaceutical logistics: 'The greatest challenge in the distribution of pharmaceuticals lies in the constant temperature chain, which must also be maintained on the last mile. Already 32 of the TOP 50 drugs are subject to strict temperature control and this number will continue to increase in the coming years. Our extremely easy-to-use technology makes handling within this last leg of transport very simple, even for untrained personnel. Temperature deviations can be avoided, and the optimal efficacy of the drugs and vaccines are and remain guaranteed.'
In the webinar, titled 'Solutions for a green and unbroken TempChain specifically for the Last Mile Distribution,' industry experts Julie Wolsak (Business Developer Health, PostNL), Dr. Christoph Frick (Pharmacist and Head of Quality Assurance, kohlpharma) and Fabian Eschenbach (Head of Business Unit Healthcare & Logistics, va-Q-tec) highlighted the unique challenges, as well as their solutions, for logistics on this leg of temperature-controlled supply chains.
A recording of the webinar is available from February 26 at the following link: https://va-q-tec.com/en/virtual-forum